Unexpectedly, 106 HNSCC patients treated with primary concomitant radiochemotherapy responded better, if ERCC1 expression in pretherapeutic tumor samples was high (Fig. 1). Here, ERCC1 is linked to head and neck squamous cell carcinoma.